OHSU in the news

Editas Medicine Continues to Seek Partner for Promising LCA10 CRISPR Gene Therapy

Precision Medicine Online July 24, 2024
Precision Medicine Online quotes Mark Pennesi, M.D., about the promising use of CRISPR in gene editing therapy to fix a rare form of blindness. "Some of these patients can't even read the big 'E' on the eye chart," Pennesi says. "It's not surprising that every patient doesn't have an improvement." Although some of the improvements may seem small, they could mean the difference between being able to avoid obstacles when walking and not, he notes.

The top cancer hospital in every state, per US News

Becker's Hospital Review July 23, 2024
In a Becker’s Hospital Review article recognizing the top cancer hospitals in each state, the OHSU Hospital/OHSU Knight Cancer Institute is listed as the top institution for Oregon.

Study holds hope for revolutionary flu vaccine, OHSU researchers say

The Lund Report July 23, 2024
OHSU-led research reveals a promising approach to developing a universal influenza vaccine, a platform that also could be useful against the next pandemic. Jonah Sacha, M.D., says, “For viruses of pandemic potential, it’s critical to have something like this. We set out to test influenza, but we don’t know what’s going to come next.”
See more stories